Roche says Herceptin with Pertuzumab "impressive" (Reuters)Reuters - Roche Holding AG's Herceptin combined
with Pertuzumab showed "impressive results" in a Phase II
breast cancer trial, the Swiss drugmaker said on Friday.
http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/reuters/cancer_breast_roche_dc.html